Xofluza

Xofluza

baloxavir marboxil

Manufacturer:

Roche

Distributor:

DKSH
Concise Prescribing Info
Contents
Baloxavir marboxil
Indications/Uses
Influenza in patients ≥12 yr who have been symptomatic for no >48 hr, & at high risk of developing influenza complications.
Dosage/Direction for Use
A single dose should be initiated w/in 48 hr of symptom onset. Adult & adolescent ≥12 yr weighing ≥80 kg 80 mg, 40 to <80 kg 40 mg.
Administration
May be taken with or without food: Do not take w/ dairy products, Ca-fortified beverages, laxatives, antacids, or oral supplements containing Fe, Zn, Se, Ca or Mg.
Contraindications
Special Precautions
Renal & severe hepatic impairment. Pregnancy & lactation. Ped patients <12 yr.
Drug Interactions
Plasma conc may be decreased by polyvalent-cation containing laxatives or antacids, or oral supplements containing Fe, Zn, selenium, Ca, Mg.
MIMS Class
Antivirals
ATC Classification
J05AX25 - baloxavir marboxil ; Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.
Presentation/Packing
Form
Xofluza FC tab 20 mg
Packing/Price
2's
Form
Xofluza FC tab 40 mg
Packing/Price
2's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in